Resolution Assurance | Vaping Information Clarity

Public Information Clarity / Non-Advisory

Vaping Information Clarity Audit

A daily public-information watch surface for vaping signals. It tracks official metrics, research metadata, theory status, contradictions, missing evidence, and continuity over time without offering advice.

Current clarity
82.7
High clarity

Coverage is broad, continuity is active, and the public watch surface is ready for daily tracking.

Updated 17 Apr 2026, 9:02 am | Latest run 3.5d ago
Evidence footprint 97

5 topics | 28 official metrics | 0 collection errors

Continuity 51

26 lineage rows | 26 diff rows | daily cadence active

Theory governance 18

11 false | 3 misleading | 3 unsupported

Open watchlist 29

9 contradiction clusters | 20 negative-space findings

Trajectory

Daily audit continuity

One live reading for the whole audit, refreshed from Canon 6.2 run packs without publishing the internal scoring logic.

Boundary

What this page is

Public information clarity only. Not medical advice, diagnosis, treatment guidance, smoking-cessation guidance for an individual, or a recommendation to start, stop, buy, or avoid any product.

Core regulatory position
Resolution Assurance is a non-custodial verification layer. It does not store medical records, provide medical advice, or act as a decision system.
Method posture
Built from compact public metrics, research metadata, theory governance, contradiction tracking, negative-space detection, and Canon 6.2 continuity objects. Internal scoring and orchestration rules remain unpublished.
Public markers

Quick read

Youth current users 1.63M

US youth current e-cigarette users

Poison-centre cases 7,043

US e-cigarette exposure cases reported to poison centers

Adult use 6.5%

US adult e-cigarette use

Authorized products 41

FDA-authorized e-cigarettes lawfully sellable in the US

Coverage

Topic map

Acute injury, poisoning, and child exposure

14 records
Latest year 2023 0 long-term trial records

Smoking cessation and harm reduction

23 records
Latest year 2025 6 long-term trial records

Regulation, product landscape, and market signals

22 records
Latest year 2026 6 long-term trial records

Toxicology, aerosol, and secondhand exposure

15 records
Latest year 2025 0 long-term trial records

Youth uptake and nicotine dependence

23 records
Latest year 2026 8 long-term trial records
Watchlist

Open gaps and theory pressure

Toxicology, aerosol, and secondhand exposure long term evidence gap

Fewer than two long-term registry records were detected in the capped seed run.

Toxicology, aerosol, and secondhand exposure safety followup gap

Safety-language signals were found while long-term registry coverage remained thin.

Smoking cessation and harm reduction trial results availability gap

Fewer than one quarter of seed trial records were completed records with posted results.

Acute injury, poisoning, and child exposure false

Child poisonings from vaping products are rare edge cases.

Regulation, product landscape, and market signals false

Disposable e-cigarettes are a small niche and not central to the market.

Smoking cessation and harm reduction false

Using cigarettes and vapes together is a good enough harm-reduction endpoint.